- Home
- TPG vs STVN Comparison
TPG vs STVN Comparison
Compare TPG & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPG
- STVN
- Stock Information
- Founded
- TPG 1992
- STVN 1949
- Country
- TPG United States
- STVN Italy
- Employees
- TPG N/A
- STVN N/A
- Industry
- TPG Investment Managers
- STVN Containers/Packaging
- Sector
- TPG Finance
- STVN Consumer Discretionary
- Exchange
- TPG Nasdaq
- STVN Nasdaq
- Market Cap
- TPG 6.2B
- STVN 6.6B
- IPO Year
- TPG 2022
- STVN 2021
- Fundamental
- Price
- TPG $52.49
- STVN $24.49
- Analyst Decision
- TPG Buy
- STVN Buy
- Analyst Count
- TPG 13
- STVN 6
- Target Price
- TPG $62.17
- STVN $25.08
- AVG Volume (30 Days)
- TPG 1.8M
- STVN 349.3K
- Earning Date
- TPG 08-05-2025
- STVN 08-05-2025
- Dividend Yield
- TPG 3.33%
- STVN 0.25%
- EPS Growth
- TPG N/A
- STVN N/A
- EPS
- TPG N/A
- STVN 0.50
- Revenue
- TPG $3,710,887,000.00
- STVN $1,215,562,040.00
- Revenue This Year
- TPG N/A
- STVN $8.69
- Revenue Next Year
- TPG $23.44
- STVN $10.67
- P/E Ratio
- TPG N/A
- STVN $49.48
- Revenue Growth
- TPG 44.34
- STVN 3.81
- 52 Week Low
- TPG $37.52
- STVN $16.85
- 52 Week High
- TPG $72.98
- STVN $25.88
- Technical
- Relative Strength Index (RSI)
- TPG 63.47
- STVN 60.72
- Support Level
- TPG $48.75
- STVN $22.51
- Resistance Level
- TPG $53.02
- STVN $24.80
- Average True Range (ATR)
- TPG 1.51
- STVN 1.18
- MACD
- TPG 0.23
- STVN 0.10
- Stochastic Oscillator
- TPG 95.40
- STVN 77.15
About TPG TPG Inc.
TPG Inc is an alternative asset management firm. It invests across five multi-product platforms namely Capital, Growth, Impact, Real Estate, Market Solutions, and TPG Angelo Gordon. The company focuses on large-scale, control-oriented private equity investments.
About STVN Stevanato Group S.p.A.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.